Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1130099.RAijXbBRntfYQrryRLholgCOCjh5CEFcxeHuRxRlYXNfI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1130099.RAijXbBRntfYQrryRLholgCOCjh5CEFcxeHuRxRlYXNfI130_assertion type Assertion NP1130099.RAijXbBRntfYQrryRLholgCOCjh5CEFcxeHuRxRlYXNfI130_head.
- NP1130099.RAijXbBRntfYQrryRLholgCOCjh5CEFcxeHuRxRlYXNfI130_assertion description "[Dabrafenib has been approved to treat patients with BRAF(V600E)-positive unresectable or metastatic melanoma based on its clinical benefit demonstrated in a randomized phase III study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1130099.RAijXbBRntfYQrryRLholgCOCjh5CEFcxeHuRxRlYXNfI130_provenance.
- NP1130099.RAijXbBRntfYQrryRLholgCOCjh5CEFcxeHuRxRlYXNfI130_assertion evidence source_evidence_literature NP1130099.RAijXbBRntfYQrryRLholgCOCjh5CEFcxeHuRxRlYXNfI130_provenance.
- NP1130099.RAijXbBRntfYQrryRLholgCOCjh5CEFcxeHuRxRlYXNfI130_assertion SIO_000772 24259661 NP1130099.RAijXbBRntfYQrryRLholgCOCjh5CEFcxeHuRxRlYXNfI130_provenance.
- NP1130099.RAijXbBRntfYQrryRLholgCOCjh5CEFcxeHuRxRlYXNfI130_assertion wasDerivedFrom befree-2016 NP1130099.RAijXbBRntfYQrryRLholgCOCjh5CEFcxeHuRxRlYXNfI130_provenance.
- NP1130099.RAijXbBRntfYQrryRLholgCOCjh5CEFcxeHuRxRlYXNfI130_assertion wasGeneratedBy ECO_0000203 NP1130099.RAijXbBRntfYQrryRLholgCOCjh5CEFcxeHuRxRlYXNfI130_provenance.